550 related articles for article (PubMed ID: 11797840)
1. Alpha-particle carcinogenesis in Thorotrast patients: epidemiology, dosimetry, pathology, and molecular analysis.
Ishikawa Y; Wada I; Fukumoto M
J Environ Pathol Toxicol Oncol; 2001; 20(4):311-5. PubMed ID: 11797840
[TBL] [Abstract][Full Text] [Related]
2. The relationship between internally deposited alpha-particle radiation and subsite-specific liver cancer and liver cirrhosis: an analysis of published data.
Sharp GB
J Radiat Res; 2002 Dec; 43(4):371-80. PubMed ID: 12674201
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the tumor suppressor gene p53 in human liver cancer induced by alpha-particles.
Andersson M; Jönsson M; Nielsen LL; Vyberg M; Visfeldt J; Storm HH; Wallin H
Cancer Epidemiol Biomarkers Prev; 1995; 4(7):765-70. PubMed ID: 8672994
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of death in thorotrast-exposed patients during the late follow-up period.
Kato I; Kido C
Jpn J Cancer Res; 1987 Nov; 78(11):1187-92. PubMed ID: 2826375
[TBL] [Abstract][Full Text] [Related]
5. High rate of small TP53 mutations and infrequent loss of heterozygosity in malignant liver tumors associated with thorotrast: implications for alpha-particle carcinogenesis.
Wada I; Horiuchi H; Mori M; Ishikawa Y; Fukumoto M; Mori T; Kato Y; Kitagawa T; Machinami R
Radiat Res; 1999 Dec; 152(6 Suppl):S125-7. PubMed ID: 10564952
[TBL] [Abstract][Full Text] [Related]
6. Analysis of genetic changes in intrahepatic cholangiocarcinoma induced by thorotrast.
Kamikawa T; Amenomori M; Itoh T; Momoi H; Hiai H; Machinami R; Ishikawa Y; Mori T; Shimahara Y; Yamaoka Y; Fukumoto M
Radiat Res; 1999 Dec; 152(6 Suppl):S118-24. PubMed ID: 10564951
[TBL] [Abstract][Full Text] [Related]
7. Survey of thorotrast-associated liver cancers in Japan.
Yamada S; Hosoda S; Tateno H; Kido C; Takahashi S
J Natl Cancer Inst; 1983 Jan; 70(1):31-5. PubMed ID: 6296518
[TBL] [Abstract][Full Text] [Related]
8. Quantitative comparisons of cancer induction in humans by internally deposited radionuclides and external radiation.
Harrison JD; Muirhead CR
Int J Radiat Biol; 2003 Jan; 79(1):1-13. PubMed ID: 12556326
[TBL] [Abstract][Full Text] [Related]
9. 1998 results of the first series of follow-up studies on Japanese thorotrast patients and their relationships to an autopsy series.
Mori T; Fukutomi K; Kato Y; Hatakeyama S; Machinami R; Tanooka H; Ishikawa Y; Kumatori T
Radiat Res; 1999 Dec; 152(6 Suppl):S72-80. PubMed ID: 10564941
[TBL] [Abstract][Full Text] [Related]
10. Histological type of Thorotrast-induced liver tumors associated with the translocation of deposited radionuclides.
Yamamoto Y; Chikawa J; Uegaki Y; Usuda N; Kuwahara Y; Fukumoto M
Cancer Sci; 2010 Feb; 101(2):336-40. PubMed ID: 19917057
[TBL] [Abstract][Full Text] [Related]
11. Tissue distribution of Thorotrast and role of internal irradiation in carcinogenesis.
Yamasaki K; Yamasaki A; Tosaki M; Isozumi Y; Hiai H
Oncol Rep; 2004 Oct; 12(4):733-8. PubMed ID: 15375492
[TBL] [Abstract][Full Text] [Related]
12. Primary liver tumors among Danish patients exposed to Thorotrast.
Andersson M; Vyberg M; Visfeldt J; Carstensen B; Storm HH
Radiat Res; 1994 Feb; 137(2):262-73. PubMed ID: 8134550
[TBL] [Abstract][Full Text] [Related]
13. Sporadic and Thorotrast-induced angiosarcomas of the liver manifest frequent and multiple point mutations in K-ras-2.
Przygodzki RM; Finkelstein SD; Keohavong P; Zhu D; Bakker A; Swalsky PA; Soini Y; Ishak KG; Bennett WP
Lab Invest; 1997 Jan; 76(1):153-9. PubMed ID: 9010458
[TBL] [Abstract][Full Text] [Related]
14. [Proliferative lesions in thorotrast-deposited livers pertaining to the development of primary cancers].
Tateno H; Hosoda S; Yamada S; Kido C
Gan No Rinsho; 1984 Jan; 30(1):23-34. PubMed ID: 6321822
[TBL] [Abstract][Full Text] [Related]
15. Allelotypic characteristics of thorotrast-induced intrahepatic cholangiocarcinoma: comparison to liver cancers not associated with thorotrast.
Liu D; Wada I; Tateno H; Ogino D; Suzuki M; Li L; Lu W; Kojiro M; Fukayama M; Okabe H; Fukumoto M
Radiat Res; 2004 Feb; 161(2):235-43. PubMed ID: 14731065
[TBL] [Abstract][Full Text] [Related]
16. Mortality after radiological investigation with radioactive Thorotrast: a follow-up study of up to fifty years in Portugal.
dos Santos Silva I; Malveiro F; Jones ME; Swerdlow AJ
Radiat Res; 2003 Apr; 159(4):521-34. PubMed ID: 12643797
[TBL] [Abstract][Full Text] [Related]
17. Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark.
Sorensen HT; Friis S; Olsen JH; Thulstrup AM; Mellemkjaer L; Linet M; Trichopoulos D; Vilstrup H; Olsen J
Hepatology; 1998 Oct; 28(4):921-5. PubMed ID: 9755226
[TBL] [Abstract][Full Text] [Related]
18. [Liver cirrhosis and cholangiocarcinoma following Thorotrast administration].
Vanhaecke J; Hendrickx H; Fevery J; Baert A; Vandenbroucke J; de Wolf-Peeters C; Desmet V; de Groote J
Ned Tijdschr Geneeskd; 1979 Dec; 123(52):2218-23. PubMed ID: 232542
[No Abstract] [Full Text] [Related]
19. Cancer mortality of thorotrast patients in Japan: the second series updated 1998.
Kido C; Sasaki F; Hirota Y; Kiyosawa K; Hayashi S; Mori T; Sobue T
Radiat Res; 1999 Dec; 152(6 Suppl):S81-3. PubMed ID: 10564942
[TBL] [Abstract][Full Text] [Related]
20. The german thorotrast study: recent results and assessment of risks.
van Kaick G; Dalheimer A; Hornik S; Kaul A; Liebermann D; Lührs H; Spiethoff A; Wegener K; Wesch H
Radiat Res; 1999 Dec; 152(6 Suppl):S64-71. PubMed ID: 10564940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
